Recent Posts

webinar, on-demand webinar, precision oncology, cancer
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Posted 14th March 2023

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Read More
webinar , on-demand webinar , precision oncology , cancer
The time has come to change the way we treat cancer
Posted 7th March 2023

The time has come to change the way we treat cancer

Read More
Blog , RareDiseases
The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients
Posted 24th February 2023

The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients

Read More
News
Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute
Posted 15th February 2023

Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute

Read More
Blog , careers
What’s it like to be a woman working in science?
Posted 10th February 2023

What’s it like to be a woman working in science?

Read More
Blog , on-demand webinar , DDD study
Professor Matthew Hurles discusses the Deciphering Developmental Disorders study
Posted 8th February 2023

Professor Matthew Hurles discusses the Deciphering Developmental Disorders study

Read More
News , precision oncology
Congenica announces Early Access Program for its novel Precision Oncology Solution
Posted 19th January 2023

Congenica announces Early Access Program for its novel Precision Oncology Solution

Read More
News , GCloud13 , NHS
Congenica approved as supplier on Government G-Cloud 13 framework
Posted 14th December 2022

Congenica approved as supplier on Government G-Cloud 13 framework

Read More
News , NGS , oncology
Congenica awarded European contract to develop NGS analysis workflow in oncology
Posted 6th December 2022

Congenica awarded European contract to develop NGS analysis workflow in oncology

Read More
Patient Advocacy , genomics , RareDiseases , precision medicine
The Real Costs of Rare Disease
Posted 25th November 2022

The Real Costs of Rare Disease

Read More
News , PGx
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Posted 9th November 2022

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Read More
1 2 3 4 5
... 24 next
webinar , on-demand webinar , precision oncology , cancer
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Posted 14th March 2023

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Read More
webinar , on-demand webinar , precision oncology , cancer
The time has come to change the way we treat cancer
Posted March Mar 7th 2023

The time has come to change the way we treat cancer

Read More
Blog , RareDiseases
The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients
Posted February Feb 24th 2023

The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients

Read More
News
Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute
Posted February Feb 15th 2023

Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute

Read More
Blog , careers
What’s it like to be a woman working in science?
Posted February Feb 10th 2023

What’s it like to be a woman working in science?

Read More
Blog , on-demand webinar , DDD study
Professor Matthew Hurles discusses the Deciphering Developmental Disorders study
Posted February Feb 8th 2023

Professor Matthew Hurles discusses the Deciphering Developmental Disorders study

Read More
News , precision oncology
Congenica announces Early Access Program for its novel Precision Oncology Solution
Posted January Jan 19th 2023

Congenica announces Early Access Program for its novel Precision Oncology Solution

Read More
News , GCloud13 , NHS
Congenica approved as supplier on Government G-Cloud 13 framework
Posted December Dec 14th 2022

Congenica approved as supplier on Government G-Cloud 13 framework

Read More
News , NGS , oncology
Congenica awarded European contract to develop NGS analysis workflow in oncology
Posted December Dec 6th 2022

Congenica awarded European contract to develop NGS analysis workflow in oncology

Read More
Patient Advocacy , genomics , RareDiseases , precision medicine
The Real Costs of Rare Disease
Posted November Nov 25th 2022

The Real Costs of Rare Disease

Read More
News , PGx
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Posted November Nov 9th 2022

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Read More
1 2 3 4 5
... 24 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.